Target intelligence / Profile preview

Novel transcript, antisense to TTC27 (ENSG00000295174)

Target: ENSG00000295174
Molecular classification: Long non-coding RNA (lncRNA)

Overview

ENSG00000295174 is a long non-coding RNA (lncRNA) gene, transcribed in the antisense direction relative to the protein-coding TTC27 (Tetratricopeptide repeat domain 27) gene[3]. As an antisense lncRNA, it may participate in the regulation of TTC27 via mechanisms typical of antisense transcripts, such as RNA interference, modulation of chromatin structure, transcriptional interference, or influence on mRNA stability[1][5]. However, there is currently no experimental evidence describing the specific function, disease implication, or drug interaction profile for this lncRNA. It is not classified as a receptor, enzyme, transporter, or recognized therapeutic target. It does, however, fall within the general molecular classification of "long non-coding RNA" with potential regulatory roles.

Other names: Antisense RNA to TTC27ENSG00000295174

Biological functions

Regulation of gene expression (general function of many antisense lncRNAs)potential regulation of TTC27 expression through antisense mechanisms such as modulation of transcription, chromatin remodeling, RNA stability, or alternative splicing

Disease associations

Other (Antisense lncRNAs can play roles in diverse processes, including cancer, developmental regulation, and epigenetic phenomena, but no direct disease association is established for ENSG00000295174)

Beyond the preview

Go deeper on Novel transcript, antisense to TTC27 (ENSG00000295174).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TTC27 (ENSG00000295174).

Explore the full profile